U

Universal Biosensors Inc
ASX:UBI

Watchlist Manager
Universal Biosensors Inc
ASX:UBI
Watchlist
Price: 0.014 AUD Market Closed
Market Cap: AU$4.2m

Universal Biosensors Inc
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Universal Biosensors Inc
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
U
Universal Biosensors Inc
ASX:UBI
Inventory
AU$3.3m
CAGR 3-Years
11%
CAGR 5-Years
40%
CAGR 10-Years
17%
Somnomed Ltd
ASX:SOM
Inventory
AU$7.4m
CAGR 3-Years
34%
CAGR 5-Years
27%
CAGR 10-Years
19%
Cochlear Ltd
ASX:COH
Inventory
AU$566.1m
CAGR 3-Years
26%
CAGR 5-Years
24%
CAGR 10-Years
14%
Optiscan Imaging Ltd
ASX:OIL
Inventory
AU$1.8m
CAGR 3-Years
15%
CAGR 5-Years
11%
CAGR 10-Years
51%
Austco Healthcare Ltd
ASX:AHC
Inventory
AU$9.3m
CAGR 3-Years
0%
CAGR 5-Years
12%
CAGR 10-Years
N/A
EMvision Medical Devices Ltd
ASX:EMV
Inventory
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Universal Biosensors Inc
Glance View

Market Cap
4.2m AUD
Industry
Health Care

Universal Biosensors, Inc. engages in the research, development and manufacture of medical diagnostics test systems for point-of-care professional and home use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2006-12-13. The firm is engaged in developing and commercializing a range of biosensors in oenology (wine industry), human health including oncology, coagulation, COVID-19, women’s health and fertility, non-human and environmental testing using its patented platform technology and hand-held point of use devices. Its core technology consists of a disposable, multi-layer test strip, which incorporates a proprietary electrochemical sensing system using opposing electrodes that detects specific analytes in samples as small as a droplet. Its products include Sentia, a wine analyzer, and Xprecia Prime, a coagulation analyzer. Its Hemostasis Reference Laboratory Meso Scale Discovery (MSD) multiplex platform couples immunoassay methodology with electrochemiluminescence (ECL) detection to provide measurement of a multitude of different cytokine panels. Its laboratory services include assay validation and analysis and consultation for study design.

UBI Intrinsic Value
0.054 AUD
Undervaluation 74%
Intrinsic Value
Price
U

See Also

What is Universal Biosensors Inc's Inventory?
Inventory
3.3m AUD

Based on the financial report for Jun 30, 2025, Universal Biosensors Inc's Inventory amounts to 3.3m AUD.

What is Universal Biosensors Inc's Inventory growth rate?
Inventory CAGR 10Y
17%

Over the last year, the Inventory growth was -40%. The average annual Inventory growth rates for Universal Biosensors Inc have been 11% over the past three years , 40% over the past five years , and 17% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett